$942 Million is the total value of Invesco Private Capital's 10 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGO | Assured Guaranty Ltd. | $278,297,000 | -15.0% | 14,842,488 | 0.0% | 29.53% | -12.7% | |
| BKU | Bankunited Inc. | $255,435,000 | +19.9% | 8,189,631 | 0.0% | 27.11% | +23.1% | |
| XCO | Exco Resources Inc. | $212,337,000 | -11.8% | 31,504,077 | 0.0% | 22.53% | -9.4% | |
| SNBC | Sun Bancorp Inc. | $81,499,000 | +13.0% | 21,279,241 | 0.0% | 8.65% | +16.0% | |
| CACB | Cascade Bancorp | $66,863,000 | -6.1% | 11,468,750 | 0.0% | 7.10% | -3.6% | |
| 2978PS | Sell | E2Open, Inc. | $29,638,000 | +25.3% | 1,323,110 | -2.1% | 3.14% | +28.6% |
| CALD | Sell | Callidus Software, Inc. | $10,421,000 | +8.2% | 1,136,406 | -22.2% | 1.11% | +11.0% |
| HLIT | Sell | Harmonic, Inc. | $3,729,000 | +13.2% | 485,546 | -6.4% | 0.40% | +16.1% |
| LPDX | LipoScience, Inc. | $3,621,000 | -28.5% | 724,213 | 0.0% | 0.38% | -26.6% | |
| CYCC | Cyclacel Pharmaceuticals k | $496,000 | +44.6% | 116,316 | 0.0% | 0.05% | +51.4% | |
| ZIPR | Exit | ZipRealty | $0 | – | -12,282 | -100.0% | -0.00% | – |
| SEM | Exit | Select Medical | $0 | – | -115,121 | -100.0% | -0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAVIGATOR HOLDINGS LTD. | 24 | Q3 2019 | 99.0% |
| Sun Bancorp Inc. | 19 | Q4 2017 | 35.4% |
| Exco Resources Inc. | 19 | Q4 2017 | 24.9% |
| XENON PHARMACEUTICALS, INC. | 18 | Q1 2019 | 1.0% |
| Cascade Bancorp | 16 | Q1 2017 | 20.3% |
| E2Open, Inc. Common Stock | 7 | Q4 2014 | 3.1% |
| Cyclacel Pharmaceuticals k | 7 | Q4 2014 | 0.1% |
| Talmer Bancorp Inc | 6 | Q2 2015 | 20.5% |
| LipoScience, Inc. Common Stock | 6 | Q3 2014 | 0.5% |
| Harmonic, Inc. Common Stock | 5 | Q2 2014 | 0.4% |
View Invesco Private Capital's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| E2open Inc | February 06, 2015 | 671,123 | 2.3% |
| CALLIDUS SOFTWARE INC | February 14, 2011 | 1,601,406 | 5.0% |
| MONTPELIER RE HOLDINGS LTDSold out | February 14, 2011 | 0 | 0.0% |
| Cyclacel Pharmaceuticals, Inc. | April 07, 2006 | 931,313 | - |
| SIGMATEL INC | February 11, 2005 | 447,881 | 1.3% |
| HEALTH GRADES INCSold out | March 12, 2003 | 0 | 0.0% |
| ALLOS THERAPEUTICS INC | October 02, 2002 | 861,961 | 3.8% |
| HEALTHGRADES COM INCSold out | March 23, 2001 | 0 | 0.0% |
| REPEATER TECHNOLOGIES INC | February 27, 2001 | 2,164,656 | 9.3% |
| TRANSGENOMIC INC | February 27, 2001 | 2,292,426 | 10.7% |
View Invesco Private Capital's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2019-12-05 |
| 4 | 2019-11-27 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 3 | 2019-04-08 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
View Invesco Private Capital's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.